<DOC>
	<DOCNO>NCT00504842</DOCNO>
	<brief_summary>This randomize , placebo control , parallel group dose escalation trial evaluate safety , tolerability , activity four sequential dose tier MRX-801 ultrasound adjunctive therapy tissue plasminogen activator ( tPA ) treatment subject acute ischemic stroke .</brief_summary>
	<brief_title>Transcranial Ultrasound Clinical SONothrombolysis</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>Acute ischemic stroke Occlusion demonstrate transcranial Doppler ultrasound Eligible tPA Right leave cardiac shunt Moderate severe COPD Uncontrolled hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Acute Ischemic Stroke</keyword>
	<keyword>Microbubbles</keyword>
	<keyword>Transcranial Doppler ultrasound</keyword>
	<keyword>TIBI</keyword>
	<keyword>Symptomatic Intracranial Hemorrhage</keyword>
	<keyword>modify Rankin Scale</keyword>
	<keyword>Recanalization</keyword>
	<keyword>Perflutren</keyword>
</DOC>